Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting

CompletedOBSERVATIONAL
Enrollment

573

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions
Metastatic Renal Cell Carcinoma (mRCC)
Interventions
OTHER

observational

The study is non interventional. All drugs will be prescribed

Trial Locations (110)

1000

Centre Hospitalier De Bourg En Bresse - Hopital Fleyriat, Bourg-en-Bresse

1090

AKH - Universitaetsklinik fuer Innere Medizin I, Vienna

AKH-Universitat Klinik fur Innere Medizin I, Vienna

1220

Sozialmedizinisches Zentrum Ost, Vienna

1340

Clinique St Pierre - Oncologie, Ottignies

2820

Imeldaziekenhuis, Bonheiden

4021

AKh Linz, Linz

5912

Viecuri Medical Centre, BL Venlo

7400

Krankenhaus Oberwart, Oberwart

9000

Algemeen Ziekenhuis Sint-Lucas, Dienst Oncologie, Ghent

AZ Maria Middelares, Ghent

9300

ASZ Aalst - Campus Aalst, Aalst

10060

IRCC Oncologia Medica, Candiolo (TO)

11527

"General Hospital of Chest Diseases of Athens Sotiria", Athens

11890

C.H.G. Antoine Gayraud, Medecine Interne, Carcassonne

13274

Centre Hospitalier Prive Clairval, Marseille

13385

Hopital Timone Adultes, Marseille

13915

Hopital Nord, Marseille

15006

Complexo Hospitalario Universitario A Coruña. Hospital Teresa Herrera, A Coruña

17007

Institut Catala Oncologia - Hospital Universitari de Girona Dr Josep Trueta, Girona

20100

Istituto Nazionale Tumori, Oncologia Medica B, Milan

21000

Centre d'Oncologie du Parc, Dijon

Clinique Clement Drevon, Dijon

22015

Cl Armoricaine Radiologie / Radiotherapie, Saint-Brieuc

24000

Polyclinique de Francheville, Périgueux

24071

Hospital de Leon, León

26000

Centre Hospitalier du Marechal Juin, Valence

27100

IRCCS Policlinico San Matteo, Pavia

28007

Hospital General Universitario Gregorio Marañon, Madrid

28031

Hospital Infanta Leonor, Madrid

28034

Hospital Universitario Ramon y Cajal, Madrid

28040

Hospital Clinico San Carlos, Madrid

28041

Servicio de Oncologia Medica, Madrid

28805

Hospital Principe de Asturias, Alcalá de Henares

30008

Hospital Morales Meseguer, Murcia

30029

Hôpital Universitaire Carémeau, Nîmes

31008

Hospital de Navarra, Pamplona

33000

Clinique Bordeaux Tivoli Ducos, Bordeaux

33075

Hôpital Saint-André, Bordeaux

33076

Institut Bergonie, Bordeaux

34070

Clinique Clémentville - Oncologie, Montpellier

35760

CHP Saint Gregoire, Saint-Grégoire

35768

Centre Hospitalier Prive Saint Gregoire, Saint-Grégoire

36211

Centro Médico, Vigo

36312

H. U. de Vigo- Hospital Álvaro Cunqueiro/Servicio de Oncologia Medica, Vigo

37007

Hospital Universitario de Salamanca, Salamanca

38320

Hospital Universitario de Canarias, Santa Cruz de Tenerife

44600

Pôle Hospitalier Mutualiste, Saint-Nazaire

44805

Centre Rene Gauducheau - Service Oncologie Medicale, Saint-Herblain

45004

Hospital Virgen de La Salud, Toledo

46010

Hospital Clinico Universitario de Valencia, Valencia

46017

Salud Hospital Universitario Dr. Peset, Valencia

46026

Centro Sanitario Hospital Universitario y Politecnico La Fe, Valencia

47000

Cl du Docteur Calabet / Cromg, Agen

47014

Divisione di Oncologia Medica, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola (FC)

49100

CHU Angers - Hôpital Hôtel Dieu, Angers

51056

Institut Jean Godinot, Reims

54100

Centre d'Oncologie de Gentilly, Nancy

Centre d'Oncology de Gentilly, Nancy

54511

Centre Alexis Vautrin, Vandœuvre-lès-Nancy

57045

Hopital Belle-Isle, Metz

57072

Hopital Clinique Claude-Bernard, Metz

59042

Hopital prive La Louviere, Lille

59300

Clinique les Dentellieres, Valenciennes

Hopital Jean BERNARD - Tours - 7eme etage, Valenciennes

63003

CHU Gabriel Montpied, Clermont-Ferrand

63011

Centre Jean Perrin, Clermont-Ferrand

63050

Pole Sante Republique, Clermont-Ferrand

64000

Centre Hospitalier de Pau, Pau

64100

Centre d'Oncologie et de Radiotherapie du pays Basque, Bayonne

66330

Centre Catalan Urologie Andrologie, Cabestany

67010

Centre de Radiothérapie,, Strasbourg

67098

Hopital de Hautepierre-Service Oncologie at Hematologie, Strasbourg

69337

Clinique de la Sauvegarde, Lyon

69495

Centre Hospitalier Lyon Sud - Service d oncologie medicale, Pierre-Bénite

Centre Hospitalier Lyon Sud, Pierre-Bénite

71100

Hopital Prive Sainte Marie, Chalon-sur-Saône

74203

Hopital Georges Pianta, Thonon-les-Bains

74374

CH Annecy Genevois, Pringy

CHR Annecy, Pringy

80131

Divisione di Oncologia, AORN Antonio Cardarelli, Napoli

Istituto per lo Studio e la Cura dei Tumori Fondazione Pascale, Napoli

83000

Hopital Sainte Musse, Toulon

83400

Clinique Sainte Marguerite, Hyères

84082

Institut Sainte Catherine, Department Oncologie, Medecine Interene, Avignon

87042

Hopital Dupuytren - Oncologie Medicale, Limoges

89011

Centre Hospitalier d'Auxerre, Auxerre

91160

Centre Hospitalier de Longjumeau, Longjumeau

92151

Hopital FOCH, Suresnes

93370

Groupe Hospitalier Intercommunal le Raincy Montfermeil, Montfermeil

95303

CH Rene Dubos, Cergy-Pontoise

97410

Groupe Hospitaier Sud Reunion, Saint-Pierre

97449

Centre Hospitalier Sud Reunion, Saint-Pierre-des-Corps

A-6900

Landeskrankenhaus Bregenz, Bregenz

A-4010

Krankenhaus der Barmherzigen Schwestern Linz Abteilung fuer Urologie, Linz

A-5020

Universitasklinik für Urologie und Andrologie, Salzburg

06189

Centre Antoine Lacassagne, Service d'Oncologie, Nice

08208

Consorcio Hospitalario Parc Tauli, Sabadell

03010

Hospital General Universitario de Alicante, Alicante

08003

Hospital Sant Pau, Barcelona

08036

Hospital Clinic i Provincial de Barcelona, Barcelona

09071

Hospital General Yague, Burgos

GL53 7AN

Consultant Oncologist, Cheltenham

CT1

Kent & Canterbury Hospital, Canterbury

GU2 7XX

Royal Surrey County Hospital, Guildford

DD1 9SY

Department of Cancer Medicine, Dundee

BA1 3NG

Royal United Hospital Bath NHS, Bath

HU16 5JQ

Department of Academic Oncology, Cottingham

SW3 7JJ

Royal Marsden Hospital, Royal Marsden NHS Foundation Trust, London

M20 4BX

Christie Hospital NHS Trust, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02184416 - Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting | Biotech Hunter | Biotech Hunter